Sign in
4

Changes in Ownership

Oruka Therapeutics, Inc. Filed Acc 0000907654-26-000079

Chief Medical Officer sold 7,000 shares at an average $111.84 ($782,882)

  • Chief Medical Officer acquired 7,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Goncalves Joana · Chief Medical Officer

Table I: Non-derivative

6 lines
Date Transaction Shares Price Value Owned after D/I
2026-08-17 Exercise or conversion : show line 1 in the form 10b5-1 +3,500 $6.84 $23,940 36,218 D
2026-08-17 Exercise or conversion : show line 2 in the form 10b5-1 +3,500 $7.80 $27,300 39,718 D
2026-08-17 Sale : show line 3 in the form 10b5-1 −900 $109.65 $98,687 38,818 D
2026-08-17 Sale : show line 4 in the form 10b5-1 −300 $110.52 $33,155 38,518 D
2026-08-17 Sale : show line 5 in the form 10b5-1 −3,320 $112.01 $371,886 35,198 D
2026-08-17 Sale : show line 6 in the form 10b5-1 −2,480 $112.56 $279,154 32,718 D
Open-market sales · 7,000 sh · avg $111.84 · $782,882

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2026-08-17 Exercise or conversion : show line 7 in the form 10b5-1 Employee Stock Option (right to buy) −3,500 197,063 D
2026-08-17 Exercise or conversion : show line 8 in the form 10b5-1 Employee Warrant (right to buy) −3,500 168,492 D
Loading xslF345X06/form4.xml…